DNA
Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. (DNA) has 6 SEC Form 4 filings (16 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 20, 2026.
The most active filer is See remarks Coen Steven P. with 4 filings. Insiders have net sold $1.8M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Jason Kelly
- Employees:485
- HQ:Boston, MA, US
- IPO:2021-04-19
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.8M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$489.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| See remarks | Sale | 752 | $6K | Jul 20 | SEC ↗ | |
| See remarks | Sale | 307 | $3K | May 26 | SEC ↗ | |
| See remarks | Sale | 324 | $3K | Apr 20 | SEC ↗ | |
Coen Steven P.First filing | See remarks | Sale | 33,171 | $213K | Apr 14 | SEC ↗ |
Shetty Reshma P.First filing | See remarks | Sale | 124,727 | $802K | Apr 13 | SEC ↗ |
Canton BarryFirst filing | 10% Owner | Sale | 124,727 | $802K | Apr 13 | SEC ↗ |
Related companies
Ginkgo Bioworks Holdings, Inc. is in the Healthcare sector.